Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma
Conditions
Metastatic Melanoma · Advanced Locoregional Melanoma · Metastatic Renal Cell Carcinoma · Clear Cell Histology
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Study leads
Stephanie L Goff, M.D.
Principal Investigator
National Cancer Institute (NCI)